BioAtla (BCAB) Total Non-Current Liabilities (2020 - 2026)

BioAtla (BCAB) has reported Total Non-Current Liabilities for 7 consecutive years, with $25.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities rose 7.76% year-over-year to $25.9 million; the trailing twelve-month figure through Jun 2026 stood at $25.9 million (up 7.76% YoY), and the FY2025 full-year result was $30.2 million, up 64.63% from the prior year.
• Total Non-Current Liabilities fell to $25.9 million in Q2 2026 per BCAB's latest filing, from $26.1 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $36.9 million in Q3 2023 and bottomed at $17.5 million in Q2 2024.
• Historically, Total Non-Current Liabilities has averaged $25.4 million across 5 years, with a median of $26.0 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities sank 50.55% in 2024, then jumped 64.63% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $25.6 million in 2022, then increased by 14.02% to $29.2 million in 2023, then tumbled by 37.11% to $18.4 million in 2024, then surged by 64.63% to $30.2 million in 2025, then slipped by 14.15% to $25.9 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $25.9 million, $26.1 million, and $30.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.